Virtus LifeSci Financial Indicators Patterns

BBC -- USA Etf  

USD 24.47  0.0034  0.0139%

Use fundamental data analysis to confirm all available indicators of Virtus LifeSci Biotech to find out if markets are presently mispricing the entity. We found ten available drivers for Virtus LifeSci Biotech Clinical Trls ETF which can be compared to its competition. Please use Virtus LifeSci Total Asset, and the relationship between Price to Sales and Three Year Return to make a decision on weather Virtus LifeSci Biotech is priced fairly. Use Virtus LifeSci to protect against small markets fluctuations. The etf experiences normal downward trend and little activity. Check odds of Virtus LifeSci to be traded at $24.23 in 30 days

Virtus LifeSci Company Summary

Virtus LifeSci competes with iShares Nasdaq, First Trust, PowerShares Dynamic, SPDR SP, and Principal Healthcare. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on Archipelago Exchange in USA.

Virtus LifeSci Net Asset vs Price to Sales

Virtus LifeSci Biotech Clinical Trls ETF is rated below average in net asset as compared to similar ETFs. It is rated below average in price to sales as compared to similar ETFs . The ratio of Net Asset to Price to Sales for Virtus LifeSci Biotech Clinical Trls ETF is about  17,241,206 

Virtus LifeSci Biotech Systematic Risk

The output start index for this execution was fifteen with a total number of output elements of twenty-four. The Beta measures systematic risk based on how returns on Virtus LifeSci Biotech correlated with the market. If Beta is less than 0 Virtus LifeSci generally moves in the opposite direction as compared to the market. If Virtus LifeSci Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Virtus LifeSci Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Virtus LifeSci is generally in the same direction as the market. If Beta > 1 Virtus LifeSci moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Virtus LifeSci Financial Distress Probability

42%
Chance of Financial Distress
Virtus LifeSci Biotech Clinical Trls ETF has less than 42 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Virtus LifeSci

Compare Virtus LifeSci To Peers

Virtus LifeSci Opportunity Range

December 18, 2018 Opportunity Range

Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com